Common Contracts
11 similar Sales Agreement contracts by Mirati Therapeutics, Inc., 22nd Century Group, Inc., Agios Pharmaceuticals, Inc., others
MERSANA THERAPEUTICS, INC. common stock SALES AGREEMENTSales Agreement • February 28th, 2024 • Mersana Therapeutics, Inc. • Pharmaceutical preparations • New York
Mersana Therapeutics, Inc., a Delaware Corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
22nd Century group, inc. common stock SALES AGREEMENTSales Agreement • March 10th, 2023 • 22nd Century Group, Inc. • Cigarettes • New York
ROCKET PHARMACEUTICALS, INC. $200,000,000 SHARES COMMON STOCK SALES AGREEMENTSales Agreement • March 1st, 2022 • Rocket Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Rocket Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
MIRATI THERAPEUTICS, INC. COMMON STOCK AMENDED AND RESTATED SALES AGREEMENTSales Agreement • July 2nd, 2021 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • New York
Reference is made to that certain Sales Agreement, entered into as of July 2, 2020 (the “Original Sales Agreement”), by and between Mirati Therapeutics, Inc. (the “Company”) and Cowen and Company, LLC (“Cowen”), as sales agent. The Company and Cowen now intend to enter into this Amended and Restated Sales Agreement (this “Agreement”) to amend and restate the terms of the Original Sales Agreement in its entirety. Therefore, the Company and Cowen confirm as follows:
NEKTAR THERAPEUTICS COMMON STOCK SALES AGREEMENTSales Agreement • March 12th, 2021 • Nektar Therapeutics • Pharmaceutical preparations • New York
KEZAR LIFE SCIENCES, INC. SALES AGREEMENTSales Agreement • September 11th, 2020 • Kezar Life Sciences, Inc. • Pharmaceutical preparations • New York
MOLECULAR TEMPLATES, INC. Common Stock (par value $0.001 per share) SALES AGREEMENTSales Agreement • August 7th, 2020 • Molecular Templates, Inc. • Pharmaceutical preparations • New York
Molecular Templates, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
MIRATI THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • July 2nd, 2020 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • New York
Mirati Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
EX-10.1 3 petx-20171218xex10_1.htm EX-10.1 Aratana Therapeutics, Inc. COmmon Stock SALES AGREEMENT December 18, 2017 Cowen and Company, LLC 599 Lexington Avenue New York, NY 10022 Ladies and Gentlemen:Sales Agreement • May 5th, 2020 • New York
Aratana Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
AGIOS PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • April 30th, 2020 • Agios Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Agios Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
Aratana Therapeutics, Inc. COmmon Stock SALES AGREEMENTSales Agreement • December 18th, 2017 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
Aratana Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
